Back

The effects on global health outcomes of switching from regular salt to potassium-enriched salt: a modelling study

Huang, L.; Xu, X.; Matsushita, K.; Brady, T. M.; Appel, L. J.; Hoorn, E. J.; Tian, M.; Aminde, L. N.; Trieu, K.; Neal, B.; Marklund, M.

2026-04-07 epidemiology
10.64898/2026.04.06.26350270 medRxiv
Show abstract

ABSTRACT Objective To estimate the benefit and risk of replacing regular salt with potassium-enriched salt. Design Comparative risk assessment modelling. Setting Worldwide Participants Adult populations aged 25 and above. Intervention (1) worldwide replacement of all salt (discretionary salt used for seasoning or cooking in the home, and non-discretionary salt used in processed and restaurant foods); (2) worldwide replacement of just discretionary salt; (3) worldwide replacement of just non-discretionary salt; (4) replacement of discretionary salt just for people with diagnosed hypertension; and (5) replacement of discretionary salt just for people with treated hypertension. Main outcome measures For scenarios 1-3, we estimated benefits including deaths, new cases and disability-adjusted-life-years (DALYs) from cardiovascular disease and chronic kidney disease (CKD), from blood pressure-lowering as well as harms (CVD deaths) caused by hyperkalaemia among people with CKD stages G3-G5. Results Replacement of all salt worldwide could prevent 2.96 (95% uncertainty interval 2.81-3.12) million deaths, 10.17 (9.59-10.70) million new cases of disease and 69.43 (65.61-72.92) million disability-adjusted life years (DALYs) each year. These figures represent 14.6%, 13.1% and 16.5% of the annual global disease burden attributable to CVD and CKD. Replacement of all discretionary salt (1.85, 1.74-1.97 million deaths) would have a greater impact on mortality than replacement of all non-discretionary salt (1.56, 1.46-1.67 million deaths). In people with CKD Stage G3-G5, there would be a net benefit - replacement of all salt would prevent 0.75 (0.71-0.80) million deaths but might cause 0.10 (0.09-0.11) million deaths from hyperkalaemia. Discretionary salt replacement only among diagnosed or treated hypertensives would prevent 0.59 (0.55-0.63) million and 0.48 (0.45-0.52) million deaths, respectively. Conclusion Switching regular salt to potassium-enriched salt appears to offer large potential for health gains under diverse scenarios, including for people with CKD.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
PLOS Medicine
98 papers in training set
Top 0.1%
18.6%
2
Circulation
66 papers in training set
Top 0.4%
9.1%
3
PLOS ONE
4510 papers in training set
Top 32%
4.8%
4
Hypertension
32 papers in training set
Top 0.2%
4.3%
5
BMC Medicine
163 papers in training set
Top 1%
4.0%
6
Journal of the American Society of Nephrology
52 papers in training set
Top 0.3%
3.7%
7
BMC Nephrology
13 papers in training set
Top 0.1%
3.6%
8
British Journal of Clinical Pharmacology
21 papers in training set
Top 0.2%
3.6%
50% of probability mass above
9
Diabetologia
36 papers in training set
Top 0.4%
2.7%
10
Scientific Reports
3102 papers in training set
Top 44%
2.7%
11
Nature Communications
4913 papers in training set
Top 47%
2.1%
12
Trials
25 papers in training set
Top 0.8%
1.7%
13
Diabetes, Obesity and Metabolism
17 papers in training set
Top 0.3%
1.7%
14
Clinical Infectious Diseases
231 papers in training set
Top 3%
1.7%
15
Journal of the American Heart Association
119 papers in training set
Top 3%
1.7%
16
BMC Infectious Diseases
118 papers in training set
Top 3%
1.5%
17
Pharmacoepidemiology and Drug Safety
13 papers in training set
Top 0.2%
1.5%
18
BMJ Open
554 papers in training set
Top 10%
1.5%
19
International Journal of Epidemiology
74 papers in training set
Top 2%
1.3%
20
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 1%
1.2%
21
BMJ Open Diabetes Research & Care
15 papers in training set
Top 0.9%
0.9%
22
JAMA Network Open
127 papers in training set
Top 4%
0.9%
23
British Journal of General Practice
22 papers in training set
Top 0.5%
0.9%
24
The Lancet Digital Health
25 papers in training set
Top 1%
0.7%
25
Nutrients
64 papers in training set
Top 2%
0.7%
26
BMC Cardiovascular Disorders
14 papers in training set
Top 2%
0.7%
27
Eurosurveillance
80 papers in training set
Top 2%
0.7%
28
Clinical Pharmacology & Therapeutics
25 papers in training set
Top 0.9%
0.6%
29
eBioMedicine
130 papers in training set
Top 5%
0.6%
30
Kidney360
22 papers in training set
Top 0.6%
0.6%